Healthy Volunteer Clinical Trial
Official title:
A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study
This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Three tissue parameters will be used to analyze the pressure effects in two ways: within- and across-subject variability. Measurements will be taken under the tongue and on the inside of the cheek. The device is noninvasive and is approved for preclinical use.
PURPOSE OF THE STUDY:
1. There exist significant systematic and random errors in the in vivo spectroscopic
measurement of tissue hemoglobin concentrations, blood oxygenation, and scattering
coefficient due to uncontrolled probe-to-tissue interface and the lack of a real-time
calibration.
2. It is possible to design and engineer a fiber optic sensor to perform accurate and
reproducible diffuse reflectance spectroscopy (DRS) for noninvasive quantification of
tissue physiology and morphology in vivo. Features such as probe pressure control and
instrument self-calibration will improve signal-to-noise ratios by removing user bias
from optical measurements.
STUDY OBJECTIVES
1) Evaluation of the pressure sensor in healthy volunteers to determine the minimum contact
pressure required for spectroscopic measurements
DESIGN AND PROCEDURES:
Evaluation of the pressure sensor in a volunteer study (n=10)
Informed consent will be obtained from all volunteers. In order to assess the pressure
sensor, all research procedures will be repeated twice (once with the aid of the stepper
motor and once without the aid of the stepper motor.) For the first five subjects,
measurements will be made with the stepper motor first followed by measurements without the
stepper motor. The remaining five-subjects will receive the measurements in the reverse
order (no stepper motor following by stepper motor). Before the optical measurements, all
subjects will be asked to rinse their mouth with a 0.9% saline solution in order to minimize
the influence of consumed food. The instrument is high-level disinfected prior to each use
in cidex or sterilized by ethylene oxide per standard clinical procedure. Furthermore, it is
not anticipated that this device will pose a significant risk to vulnerable populations. The
probe will be covered with an optically clear protective sterile sheath and placed in
contact with the soft tissue. Reflectance measurements will be taken from each volunteer at
up to 5 pressure levels (25, 50, 75, 100, 150 mmHg). At each pressure level 10 spectra will
be acquired sequentially. The first measurement will start immediately after the desired
probe pressure is reached. This will generate a total of 100 sample and calibration spectra
pairs from each subject. This will be repeated on other sites including the tongue, cheek
and gums. The sample spectrum will be calibrated using the calibration spectrum collected
concurrently. Three tissue parameters will be used to analyze the pressure effects which is
described here with [THb] as an example: First, the mean [THb] and its standard deviation
will be calculated from the 10 repeat measurements at each pressure for each subject for
measurements with and without the stepper motor and plotted against the probe pressure
(refer to as THb-P curve). Second, at each pressure level, the [THb] will be plotted against
time for each subject and the curve will indicate the temporal response of the tissue under
that probe pressure. A series of paired t-tests will be used to identify the contact
pressure at which minimal [THb] variance occurs over time (when stepper motor is used).
Next, the variance at that contact pressure will be compared to the case without the stepper
motor to demonstrate a significant reduction in pressure variance.
The investigators do not anticipate any risks to participants, however, there are a few
potential minimal risks such as loss of confidentiality; slight risk of infection;
discomfort at the pressure sites; and jaw discomfort as a result of the mouth being opened
for several minutes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT06326723 -
Investigate the PK, Safety, and Tolerability After Single and Multiple Dose Daridorexant in Chinese Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT00001367 -
Diagnosis and History Study of Patients With Different Neurological Conditions
|
||
| Completed |
NCT02699710 -
Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics (PK) of GDC-0853 and the Effect of GDC-0853 on the PK of Methotrexate in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT02231892 -
Repetitive Transcranial Magnetic Stimulation Equipment Testing and Pilot Study
|
N/A | |
| Not yet recruiting |
NCT06441916 -
Bioequivalence Study of Dabigatran Etexilate Capsules 150 mg in Healthy Thai Volunteers Under Fasting Conditions
|
Phase 1 | |
| Completed |
NCT03771586 -
A Study to Assess the Electrophysiology, Safety, Tolerability, and Pharmacokinetics of SAGE-718 Using a Ketamine Challenge in Healthy Subjects
|
Phase 1 | |
| Not yet recruiting |
NCT06337422 -
Bioequivalence Study of Generic Celecoxib 200 mg Capsules
|
Phase 1 | |
| Completed |
NCT03302182 -
Bioequivalence Study of Ritonavir Versus NORVIR in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT05049343 -
Study of SAGE-904 Using a Ketamine Challenge to Evaluate Electrophysiology, Safety, Tolerability, and Pharmacokinetics in Healthy Participants
|
Phase 1 | |
| Recruiting |
NCT01629108 -
Normal Values in Hearing and Balance Testing
|
||
| Completed |
NCT02947854 -
Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant
|
Phase 1 | |
| Completed |
NCT02534870 -
Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT02224053 -
Drug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01697436 -
A Bioequivalence Study of an Oral Solution of Copegus (Ribavirin) Compared to Copegus Tablets
|
Phase 1 | |
| Completed |
NCT01684891 -
A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT01711762 -
A Pharmacokinetics Study of Radioactive-Labeled GDC-0973 in Healthy Male Volunteers
|
Phase 1 | |
| Completed |
NCT01676584 -
A Study of Single Dose RO6811135 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01591850 -
A Drug-Drug Interaction Study of Ketoconazole, Rifampicin and Ritonavir-Boosted Atazanavir With Single-Dose RO5093151 in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT01433575 -
A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers
|
Phase 1 | |
| Completed |
NCT01414881 -
Study to Assess the Effects of Mipomersen on Lipid and Lipoprotein Metabolism in Healthy Subjects
|
Phase 1 |